Literature DB >> 10570975

Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation.

C Liu1, X J Liu, P D Crowe, G S Kelner, J Fan, G Barry, F Manu, N Ling, E B De Souza, R A Maki.   

Abstract

NOV (nephroblastoma overexpressed gene) is a member of the CCN (connective tissue growth factor [CTGF], Cyr61/Cef10, NOV) family of proteins. These proteins are cysteine-rich and are noted for having growth-regulatory functions. We have isolated the rat NOV gene, and the DNA sequence shares 90% identity with the mouse and 80% identity with the human sequences. The rat NOV gene was expressed in all rat tissues examined, including brain, lung, heart, kidney, liver, spleen, thymus and skeletal muscle. Higher levels of rat NOV mRNA were seen in the brain, lung and skeletal muscle compared to the other tissues. Examination of NOV expression in various human cell lines revealed that NOV was expressed in U87, 293, T98G, SK-N-MC and Hs683 but not in HepG2, HL60, THP1 and Jurkat. The human NOV gene was transfected into 293 cells and the expressed protein purified. When 3T3 fibroblasts were treated with this recombinant NOV protein, a dose-dependent increase in proliferation was observed. Analysis of tyrosine-phosphorylated proteins revealed that when 3T3 cells were treated with NOV, a 221 kDa protein was phosphorylated. These data suggest that NOV can act as a growth factor for some cells and binds to a specific receptor that leads to the phosphorylation of a 221 kDa protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570975     DOI: 10.1016/s0378-1119(99)00364-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  16 in total

1.  CCN3: Doctor Jekyll and Mister Hyde.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2008-09-12       Impact factor: 5.782

2.  Nephroblastoma overexpressed gene (NOV) enhances RCC cell motility through upregulation of ICAM-1 and COX-2 expression via Akt pathway.

Authors:  Shuai Liu; Liping Han; Xiaoqing Wang; Zheng Liu; Sentai Ding; Jiaju Lu; Dongbin Bi; Yikun Mei; Zhihong Niu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 3.  The concept of the CCN protein family revisited: a centralized coordination network.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2018-02-22       Impact factor: 5.782

4.  CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.

Authors:  Erawan Borkham-Kamphorst; Claudia R van Roeyen; Eddy Van de Leur; Jürgen Floege; Ralf Weiskirchen
Journal:  J Cell Commun Signal       Date:  2011-07-05       Impact factor: 5.782

5.  The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated.

Authors:  B Y Su; W Q Cai; C G Zhang; V Martinez; A Lombet; B Perbal
Journal:  Mol Pathol       Date:  2001-06

6.  Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV).

Authors:  N Gupta; H Wang; T L McLeod; C C Naus; S Kyurkchiev; S Advani; J Yu; B Perbal; R R Weichselbaum
Journal:  Mol Pathol       Date:  2001-10

7.  CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.

Authors:  Bruce L Riser; Feridoon Najmabadi; Bernard Perbal; Jo Ann Rambow; Melisa L Riser; Ernest Sukowski; Herman Yeger; Sarah C Riser; Darryl R Peterson
Journal:  J Cell Commun Signal       Date:  2010-02-09       Impact factor: 5.782

8.  CCN3 (NOV) regulates proliferation, adhesion, migration and invasion in clear cell renal cell carcinoma.

Authors:  Shuai Liu; Zheng Liu; Dongbin Bi; Xaodong Yuan; Xiaowen Liu; Sentai Ding; Jiaju Lu; Zhihong Niu
Journal:  Oncol Lett       Date:  2012-02-13       Impact factor: 2.967

9.  A novel role of CCN3 in regulating endothelial inflammation.

Authors:  Zhiyong Lin; Viswanath Natesan; Hong Shi; Anne Hamik; Daiji Kawanami; Caili Hao; Ganapati H Mahabaleshwar; Weiye Wang; Zheng-Gen Jin; G Brandon Atkins; Sue M Firth; Laure Rittié; Bernard Perbal; Mukesh K Jain
Journal:  J Cell Commun Signal       Date:  2010-08-11       Impact factor: 5.782

10.  CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.

Authors:  Bruce L Riser; Feridoon Najmabadi; Bernard Perbal; Darryl R Peterson; Jo Ann Rambow; Melisa L Riser; Ernest Sukowski; Herman Yeger; Sarah C Riser
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.